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ABSTRACT A cDNA coding for human interleukin 2
(IL-2) was inserted into the genome of Autographa caljfornica
nuclear polyhedrosis virus adjacent to the polyhedrin promot-
er. Cells infected with recombinant virus produced high levels
of Mr 15,500 IL-2 polypeptide, the majority of which was
secreted into the culture medinm during infection. The recom-
binant IL-2 was able to stimulate the growth of an IL-2-de-
pendent cell line. The N-terminal amino acid sequence of the
insect-derived IL-2 was identical to that of natural IL-2. Thus,
a mammalian signal peptide was recognized and properly
removed in insect cells.
A variety ofprokaryotic and eukaryotic host/vector systems
are available for the production of large quantities of proteins
from cloned genes. For many applications, such as structural
analysis, determination of biological specificity, vaccine
production, diagnostics, and therapeutics, it may be desirable
or even necessary that a recombinant gene product be
identical to the natural protein made in vivo. Therefore, not
only must a cloned gene be transcribed faithfully and the
message translated, but the product must be properly mod-
ified, through such processes as glycosylation, cleavage of a
signal peptide, disulfide-bridge formation, and proper fold-
ing. The development of host/vector systems that will
process and modify recombinant proteins, in addition to
producing them at high levels, is thus an important prereq-
uisite for the production of such proteins.
Recently, the baculovirus Autographa californica nuclear
polyhedrosis virus (AcNPV) was shown to be suitable as a
helper-independent, viral expression vector for the efficient
production in cultured insect cells of proteins from cloned
genes. Human fibroblast interferon (IFN-,/; ref. 1) and a
fusion protein between AcNPV polyhedrin and Escherichia
coli /3-galactosidase (2) are expressed at very high levels in
cells infected with AcNPV recombinant viruses. More im-
portant, IFN-P is glycosylated by an N-linked glycan, the
pre-IFN-(3 signal polypeptide is removed, and the protein is
secreted efficiently (1). We are undertaking studies to deter-
mine how proteins from higher eukaryotes are processed and
modified in insect cells infected with AcNPV expression
vectors. Such studies will help to determine whether there
are fundamental differences between invertebrate and ver-
tebrate cellular mechanisms for protein modification and will
provide the information needed to define the advantages and
limitations for using baculoviruses as expression vectors.
Human interleukin 2 (IL-2), also referred to as T-cell
growth factor, is a lymphokine required for the proliferation
of activated T cells and the long-term in vitro growth of
certain T-cell lines (3, 4). The primary structure of the human
IL-2 gene product has been deduced from nucleotide se-
quence analyses of cDNA (5, 6) and genomic (7-9) clones.
IL-2 is first synthesized as a precursor polypeptide of 153
amino acids (5, 6). Taniguchi et al. (5) proposed that cleavage
of the 20 amino acid signal peptide results in the production
of the mature IL-2 protein, which is secreted into the
extracellular fluid. cDNA clones have been used to express
recombinant human IL-2 in E. coli (6, 10) and in transfected
monkey cells (5).
Natural IL-2 has been purified to homogeneity from the
human T-cell leukemia line Jurkat (11, 12). Amino acid
sequencing of the Jurkat-derived material confirmed the
primary structure of the protein, deduced from the cDNA
sequence, and established the N-terminal residues after
signal peptide cleavage (12, 13). IL-2 appears to undergo
some posttranslational modifications that account for the
heterogeneity observed in size and charge (14). Approximate-
ly 40%o of Jurkat-derived IL-2 is not glycosylated (15). In
contrast to earlier reports, the majority of the IL-2 synthe-
sized by normal human peripheral blood lymphocytes ap-
pears to be glycosylated (13). Minor species of IL-2 that are
truncated at the N terminus also exist (15).
Here we describe the production of IL-2 in insect cells,
using AcNPV as an expression vector. IL-2 was efficiently
produced and the majority of the protein was secreted from
the infected cells as a nonglycosylated protein. Sequence
analysis of the N-terminal end of the secreted IL-2 indicated
that the 20 amino acid signal peptide was accurately re-
moved.
EXPERIMENTAL PROCEDURE
Construction of Recombinant Viruses. The expression vec-
tors used in this study are diagrammed in Fig. 1. The plasmid
transfer vector pAc380 has a unique BamHI site at the
putative transcription initiation, or cap, site for AcNPV
polyhedrin mRNA (1). A similar vector, pAc373, was pro-
duced as described (1) with a single BamHI site 50 bp
downstream from the polyhedrin cap site; that is, 8 bp before
the polyhedrin ATG translation initiation codon. Genetic
sequences inserted at the BamHI site in pAc380 and that
utilize the polyhedrin control signals will be transcribed
without the polyhedrin leader sequences, whereas genes
inserted at the BamHI site in pAc373 will be transcribed as
fused mRNAs containing most of the polyhedrin leader
region.
The sequence coding for human IL-2 was obtained from a
cDNA library of poly(A)+ RNA from induced Jurkat cells.
This library was screened with synthetic oligonucleotide
probes derived from the published Jurkat IL-2 cDNA se-
Abbreviations: AcNPV, Autographa californica nuclear polyhedro-
sis virus; IL-2, interleukin 2; bp, base pair(s); hpi, hr postinfection.
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FIG. 1. AcNPV transfer vectors pAc373 and pAc380. The cir-
cular restriction map is of the AcNPV transfer vector pAc373. The
thick arrow marks the location of the sequence coding for polyhedrin
mRNA; numbers at restriction sites indicate distance in kilobase
pairs (kbp) from the HindIII end of the pUC8 backbone; ApR,
ampicillin resistance gene. The linear map is a detailed restriction
map of the 3-kbp Sal I fragment containing the polyhedrin gene. The
plasmid pAc380 has a deletion between -59 and +175 and a unique
BamHI site at -59, which is the cap site for polyhedrin mRNA (1).
pAc373 has a deletion between -9 and +175 and auniqueBamHI site
at -9, which is 50 bp downstream from the polyhedrin mRNA cap
site (1).
quence (5). A plasmid cDNA clone that contained the entire
coding region for human IL-2 (pIL2-2b) was isolated. This
clone has been used to express active IL-2 in E. coli
(unpublished work). To express IL-2 in insect cells, a 1-kbp
BamHI fragment from pIL-2B, which included 31 bp of 5'
nontranslated leader sequence, the entire IL-2 coding region,
and 309 bp of 3' nontranslated sequence, was excised and
inserted into the BamHI site of both pAc373 and pAc380.
Recombinant plasmids containing inserts in the correct
transcriptional orientation were designated pAc373-IL2 and
pAc380-IL2.
Transfer of IL-2 cDNA from these plasmid vectors to the
AcNPV genome was achieved by cotransfection, using the
calcium phosphate precipitation procedure. Spodoptera
frugiperda cells (106) were transfected with a mixture of 2 ,g
of pAc373-IL2 or pAc380-IL2 and 1 ,tg of purified AcNPV
DNA as described (16). Three days after transfection, the
medium had a virus titer of about 107 plaque forming units
(pfu)/ml. Approximately 1% of the plaques from these viral
progeny were formed from viruses that did not produce
nuclear-viral occlusions (occlusion-negative viruses). Sever-
al ofthe occlusion-negative viruses were plaque-purified and,
by means of restriction enzyme analysis, were found to have
acquired the IL-2 gene fragment adjacent to the polyhedrin
promoter. Recombinant viruses derived from pAc373-IL2
and pAc380-IL2 are referred to as Ac373-IL2 and Ac380-IL2,
respectively.
Production of IL-2 in S. frugiperda Cells. AcNPV recom-
binant virus stocks were grown in S. frugiperda cells (IPLB-
Sf2l-AE) using TNMFH medium (17) plus 10% fetal bovine
serum. To produce IL-2, S.frugiperda cells (107 per ml) were
infected for 1 hr with Ac373-IL2 or Ac380-IL2 at 20 pfu per
cell. The infected cells were washed once with TNMFH
medium (no serum) and then resuspended in TNMFH me-
dium plus serum at a cell density of 108 cells per ml. The
infected cells were seeded in 100- to 500-ml spinner flasks
(Bellco Glass) or in a 2-liter suspension cell fermentor (Biocul
20; Queue Systems) and incubated at 27TC.
Analysis of Proteins Produced by Recombinant Viruses.
Infected S. frugiperda cells were labeled metabolically with
either L-[35S]methionine (New England Nuclear; 80 Ci/
mmol; 1 Ci = 37 GBq) at 50 MCi/ml or D-[2-3H]mannose
(Amersham; 2 Ci/mmol), L-[6-3H]fucose (ICN; 30 Ci/mmol),
acetyl-D-[1,6-3H]glucosamine (New England Nuclear; 33.1
Ci/mmol), or D-[6-3H]galactose (ICN; 25 Ci/mmol) at 500
,Ci/ml. Labeled proteins were analyzed by NaDodSO4/12%
PAGE. Infected cells were incubated with 5 ,ug of tunicamy-
cin/ml and then labeled with 50 ,Ci of [35S]methionine/ml in
the presence of tunicamycin.
IL-2 mRNA was purified from the cytoplasm of infected
cells by hybridization-selection with pIL2-2B plasmid DNA
as described (18). The selected RNA was translated in a
wheat germ extract (Bethesda Research Laboratories) or
rabbit reticulocyte lysate prepared as described (19). In
certain experiments, dog pancreas membranes (20) were
included during translation in a reticulocyte lysate. Purified
rotavirus mRNAs were included as a positive control for the
protein-modification activity of membranes (20). Im-
munoblot analysis was performed as described (21), with
minor modifications. The development of monoclonal anti-
IL-2 antibodies will be described in detail elsewhere. Rabbit
anti-IL-2 antisera was produced by multiple subdermal in-jections of recombinant human IL-2 (100 ,ug) mixed in
complete Freund's adjuvant. The rabbits were bled 4 and 8
weeks later. Immunoprecipitation with the rabbit anti-IL-2
antisera was done as described (20).
Assay for IL-2 Activity. The IL-2 activity of the recombi-
nant material was measured by using the IL-2-dependent
murine cell line CTLL. The assay was performed in a manner
similar to that described in ref. 22. One unit of activity was
defined as the reciprocal of the dilution that yielded half-
maximal incorporation of [methyl-3H]thymidine.
Purification and Sequence Analysis of IL-2. IL-2 from insect
cells was purified by a modification of the procedure de-
scribed previously (11). The recombinant IL-2 in culture
medium from Ac373-1L2-infected S.frugiperda cells was first
concentrated by batch adsorption to silica gel under gentle
agitation for 1 hr at 4°C. The gel was recovered, washed with
0.15 M NaCl/5 mM phosphate (pH 7.5), and packed into a
chromatographic column. The IL-2 was specifically eluted
with 0.05 M sodium borate, pH 8.0/1.5 M tetrameth-
ylammonium chloride and further purified by HPLC on a
Synchropak RP-P column using an acetonitrile gradient
buffer system. For final purification, the protein was loaded
onto a Supercosil LC-308 column (20 x 4.6 mm, 5-pum
particle size) in 10 mM trifluoroacetic acid and eluted with an
acetonitrile gradient from 0 to 60% in 1 hr. Automated Edman
degradation was carried out on a gas-vapor sequencer, and
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the resulting phenylthiohydantoin amino acids were analyzed
according to a method described by Hawke et al. (23).
RESULTS
Production of IL-2 Activity in Insect Cells. The major
objectives of this study were to determine whether human
IL-2 could be produced at high levels in insect cells using a
baculovirus expression vector and whether the pre-IL-2
signal peptide would be correctly removed and the protein
secreted from the infected cells. We also wished to examine
the importance of the 5' leader sequences of the AcNPV
polyhedrin gene in the expression of foreign genes. The first
step in cloning IL-2 in AcNPV expression vectors was to
insert the human IL-2 coding sequence adjacent to the
polyhedrin promoter in the specially constructed plasmid
transfer vectors pAc373 and pAc380. A 1-kbp fragment
containing a full-length IL-2 cDNA was inserted into the
BamHI site at -9 in pAc373 and at -59 in pAc380 (Fig. 1).
The resulting chimeric transfer vectors pAc373-IL2 and
pAc380-IL2 were mixed with AcNPV DNA and then co-
precipitated with calcium phosphate. S.frugiperda cells were
transfected and the resulting viral progeny were screened for
the presence of recombinant viruses in which the polyhedrin
gene had been inactivated by the insertion of the IL-2 gene
fiagment. These recombinants do not form occlusions in
infected cells and thus have a distinctive plaque morphology
(1, 16). Restriction analysis of DNA from several of these
occlusion-negative viruses confirmed that IL-2 had been
transferred to the AcNPV genome and was in the expected
location relative to the polyhedrin promoter (data not
shown).
Cells infected with Ac373-IL2 and Ac380-IL2 viruses
secreted high levels of IL-2 activity into the culture medium
(Fig. 2). Ac380-IL2, in which the IL-2 gene was fused to the
polyhedrin promoter at a position that would exclude the
polyhedrin 5' leader sequences, produced about one-third
the level of IL-2 activity produced in cells infected with
Ac373-IL2. The IL-2 sequence in Ac373-IL2 was fused to the
polyhedrin promoter at a position such that the hybrid gene
would include the majority of the polyhedrin 5' leader
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FIG. 2. Expression ofIL-2 in Ac373-1L2- and Ac380-IL2-infected
S.frugiperda cells. Cells were infected with Ac373-IL2 orAc38O-1L2
at a cell density of 107 cells per ml. The infected cells were diluted
to 106 cells per ml in a final volume of 100 ml. At 24, 48, and 72 hr
postinfection (hpi), samples were taken and the cells were removed
by centrifugation. Cells and media were stored frozen until measured
for IL-2 biological activity. The IL-2 activity in the media of
pAc373-IL2- (o) and pAc380-IL2- (o) infected cells was determined
as described (22).
sequences. Cells infected with either of these vectors re-
leased IL-2 activity into the culture medium up to 72 hpi at
which time the infected cells were still intact. In a separate
experiment, the intracellular and extracellular levels of IL-2
were measured. At 56 hpi, approximately 67% and 72% ofthe
activity was present in the media of cells infected with
Ac373-IL2 and Ac380-IL2, respectively. Since the cells
remained intact during infection and the majority of the IL-2
activity was in the medium, IL-2 was most likely being
secreted, as opposed to being released as a result of cell lysis.
Media samples from uninfected cells and cells infected with
AcNPV had no detectable IL-2 activity.
Identification of IL-2 Produced in Infected Cells. In cells
infected with AcNPV, polyhedrin was the major cellular
protein at 48 and 72 hpi (Fig. 3, lanes 1 and 2). In cells infected
with the recombinant virus Ac373-IL2, polyhedrin was not
made and a new Mr 15,500 intracellular polypeptide accu-
mulated (Fig. 3, lanes 3 and 4). The molecular weight of
natural IL-2, as measured by NaDodSO4/PAGE, is reported
to be about 15,000 (12, 14). A Mr 15,500 protein was also
secreted and by 72 hpi was one of the major polypeptides
present in the medium (Fig. 3, lane 8). Accumulation of a
protein of Mr 15,500 was observed in cells infected with
Ac380-IL2, but at one-third the level in Ac373-IL2-infected
cells (data not shown).
To identify the IL-2 polypeptides being made, Ac373-IL2-
infected cells were incubated with [35S]methionine at 36-39
hpi, and then the labeled proteins from the infected cells and
the culture medium were immunoprecipitated with IL-2
antiserum. The Mr 15,500 polypeptide detected in stained gels
was a major labeled protein in the infected cells (Fig. 4, lane
1) and in the culture medium (Fig. 4, lane 2), and this protein
was immunoprecipitated with IL-2 antiserum (Fig. 4, lanes 3
and 4). In addition, an intracellular Mr 16,000 protein was
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FIG. 3. IL-2 in the cells and medium of Ac373-IL2-infected S.
frugiperda cells. Cells (3 x 106) were seeded in 25-cm2 tissue culture
flasks and infected for 1 hr with AcNPV or Ac373-IL2. The infected
cell monolayers were washed twice with TNMFH medium and then
incubated at 27°C in 3 ml of TNMFH medium. At 48 and 72 hpi, 5.0
x 104 cells (lanes 1-4) and 50 of medium (lanes 5-8) were treated
with sample buffer containing 2-mercaptoethanol and electropho-
resed in a 12% NaDodSO4/polyacrylamide gel; the gel was then
stained with Coomassie blue. Proteins from AcNPV-infected cells at
48 hpi (lanes 1 and 5) and 72 hpi (lanes 2 and 6) and from
Ac373-IL2-infected cells at 48 hpi (lanes 3 and 7) and 72 hpi (lanes 4
and 8) are shown. The locations of the highly expressed M, 10,000
viral protein (10K) and ofpolyhedrin (poly) are indicated (lanes 1-4).
Protein standards (lane M) and their molecular weights (Mr x 10-3,
at left) are shown.
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FIG. 4. Immunoprecipitation and cell-free translation of IL-2.
S. frugiperda cells were infected with Ac373-IL2 as described in
the legend to Fig. 3. (A) At 36 hpi, the infected cells either were
washed once with methionine-free Grace's medium and then labeled
for 3 hr with [35S]methionine (50 ,uCi/ml) or were washed once with
Grace's medium with 1/10th the normal amount of glucose and then
labeled for 3 hr with D-[2-3H]mannose (50 ,uCi/ml). Lanes 1 and 2:
[35S]methionine-labeled cellular and medium proteins, respectively.
Lanes 3 and 4: [35S]methionine-labeled cellular and medium proteins
immunoprecipitated with anti-IL-2 antibody. Lane 5: [3H]mannose-
labeled cellular proteins. Lane 6: [3H]mannose-labeled cellular
proteins immunoprecipitated with anti-IL-2 antibody. (B) IL-2
mRNA was obtained by hybrid-selection and translated in a cell-free
translation system with [35S]methionine in the presence or absence
ofdog pancreas membranes. Lane 7: IL-2 mRNA translated in wheat
germ extract. Lanes 8 and 10: IL-2 mRNA translated in a rabbit
reticulocyte lysate in the absence (lane 8) or presence (lane 10) of
membranes. Lane 9: Immunoprecipitate, obtained with anti-IL-2
antibody, of products of IL-2 mRNA translated in a reticulocyte
lysate in the presence of membranes. All samples were electropho-
resed in a NaDodSO4/12% polyacrylamide gel. The locations of the
Mr 15,500 IL-2 protein in lanes 1-4 and the M, 16,000 IL-2 protein
in lanes 1, 3, 7, 9, and 10 are indicated.
immunoprecipitated with IL-2 antiserum (Fig. 4, lane 3), but
only very low levels were detected in the culture medium
(Fig. 4, lane 4).
To investigate whether IL-2 produced in insect cells was
glycosylated, Ac373-IL2-infected cells were labeled with
tritiated D-mannose, acetyl-D-glucosamine, L-fucose, or D-
galactose. Although each of these labeled sugars was incor-
porated into one or more infected cell proteins (data not
shown), only D-[2-3H]mannose labeled a polypeptide with a
molecular weight similar to either of the two recombinant
IL-2 proteins (Fig. 4, lane 5). However, this Mr 16,000
glycoprotein was found only in the infected cells and not in
the medium and was not precipitated with IL-2 antiserum
(Fig. 4, lane 6). In addition, when infected cells were labeled
with [35S]methionine in the presence or absence of the
glycosylation inhibitor tunicamycin, the inhibitor had no
effect on the size of either the Mr 15,500 or the Mr 16,000 IL-2
proteins (data not shown), indicating that they did not have
N-linked carbohydrates. This finding is consistent with
reports that the fraction of IL-2 produced in human Jurkat
cells that is glycosylated contains no N-linked oligosacchar-
ides (12, 13, 15). Overall, these results indicated that the
insect-derived recombinant IL-2 was not glycosylated.
The Mr 16,000 IL-2 protein was somewhat larger than the
major secreted form of recombinant IL-2 and was present
primarily in the cells, suggesting that it might be pre-IL-2. To
investigate this possibility, IL-2 mRNA was obtained from
the cytoplasmic fraction of Ac373-IL2-infected cells trans-
lated in vitro in wheat germ and rabbit reticulocyte translation
systems. A Mr 16,000 polypeptide was made in the wheat
germ lysate (Fig. 4, lane 7), and a very low level ofMr 16,000
polypeptide was synthesized from IL-2 mRNA in the retic-
ulocyte lysate (Fig. 4, lane 8). Because signal peptides are not
cleaved in a wheat germ translation system (24), only pre-
IL-2 would be made. Therefore, the apparent molecular
weight of pre-IL-2 in our polyacrylamide gels was 16,000, the
same molecular weight observed for the intracellular,
nonsecreted IL-2 produced in Ac373-IL2-infected cells. The
translational block of IL-2 mRNA in the reticulocyte lysate
system was probably due to the binding and arrest of
translation of newly synthesized IL-2 signal sequences by
signal recognition particles, and the addition of dog pancreas
membranes should supply the appropriate factors to over-
come this block (see ref. 25 for review). With the addition of
membranes to the reticulocyte lysate, a Mr 16,000 polypep-
tide was synthesized from hybrid-selected mRNA (Fig. 4,
lane 10), and this protein was specifically immunoprecipi-
tated with IL-2 antiserum (Fig. 4, lane 9). Together, these
results indicate that the Mr 16,000 recombinant protein is
pre-IL2. Because this protein did not accumulate in the cells
during infection (Fig. 3), there was insufficient quantity
available for purification and sequence analysis to confirm
this hypothesis.
Purification and N-Terminal Sequence Analysis of Recom-
binant IL-2. Recombinant IL-2 was produced in serum-free
medium in a 2-liter suspension-culture fermentor containing
Ac373-1L2-infected S. frugiperda cells. IL-2 was partially
purified from about 200 ml of culture medium by batch
adsorption to silica gel and reversed-phase HPLC. The IL-2
was purified by an additional HPLC step on Suppelcosil
LC-308. The IL-2-containing fraction was submitted to Ed-
man degradation. The first 10 amino acids were determined
and found to be identical to the N-terminal sequence of
mature IL-2 (12, 13). The analysis ofthe phenylthiohydantoin
threonine derivative at the third amino acid residue indicated
that the recombinant protein was not glycosylated at this
position, as is observed in about 40% ofthe IL-2 isolated from
induced Jurkat cells (12, 13).
Comparison of Natural and Recombinant IL-2. Purified
recombinant IL-2 produced in the insect cells was compared
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FIG. 5. Analysis of purified recombinant IL-2 by gel electropho-
resis and immunoblotting. IL-2 samples and protein standards (lanes
2 and 7, Mr x 1O-3 at right in A) were reduced and electrophoresed
in NaDodSO4/15% polyacrylamide gels and then either silver-
stained (26) (A) or electrophoretically transferred to nitrocellulose for
immunoblot analysis (21) (B). The nitrocellulose sheet was probed
with monoclonal anti-IL-2 antibodies and then developed with an
anti-antibody coupled to horseradish peroxidase. Lanes 1: Recom-
binant IL-2 produced in insect cells. Lanes 5 and 6: 500 ng and 100
ng of recombinant IL-2 produced in E. coli. Lanes 3 and 4: IL-2
produced in Jurkat cells. Lanes 3 and 4 represent different amounts
of the same sample.
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to both Jurkat-derived and E. coli-synthesized IL-2 (Fig. 5).
The IL-2 species could be detected either by silver stain (Fig.
SA) or 'by immunoblot analysis (Fig. SB). Analysis in
NaDodSO4/polyacrylamide gels revealed that the purified
insect-cell material separated into two components, a major
species at Mr 15,500 and a minor species at Mr 16,000 (Fig.
5A, lane 1). The Mr 15,500 species comigrated with purified
recombinant E. coli IL-2 (Fig. SA, lanes 5 and 6) and with the
major species of IL-2 purified from Jurkat cells (Fig. SA,
lanes 3 and 4). Immunoblot analysis showed that these
components were all immunoreactive with monoclonal anti-
IL-2 antibodies (Fig. SB). The minor components in the
Jurkat-derived material, which migrate slightly slower than
the major component, may represent variants in glycosyla-
tion (14, 15).
The purified recombinant IL-2 from insect and E. coli cells
and purified natural IL-2 from human Jurkat cells were
compared for their ability to stimulate the growth of an IL-2
dependent T-cell line. The IL-2 specific activity, measured as
described in ref. 22, for these proteins were between 0.5 and
1.0 x 108 units/mg, or within the factor-of-2 error inherent in
this assay.
DISCUSSION
In this study we demonstrated that (i) recombinant IL-2 was
expressed at high levels under the transcriptional control of
the AcNPV polyhedrin promoter; (it) higher levels of expres-
sion were obtained when the IL-2 gene was inserted into an
AcNPV expression vector that included the polyhedrin 5'
leader sequences; (iii) protein-processing mechanisms within
the insect cell recognized the pre-IL-2 signal peptide and
cleaved the amino acid sequence at the correct position; and
(iv) the majority of the IL-2 was secreted. There was no
evidence that the recombinant IL-2 produced in insect cells
was glycosylated. However, about 40% of the natural IL-2
produced in human Jurkat cells is not glycosylated (12), and
modifications such as glycosylation do not appear to be
required for IL-2 bioactivity (10).
There were two intracellular forms of IL-2 produced in
Ac373-IL2-infected cells: a Mr 15,500 protein that was
efficiently secreted and a Mr 16,000 protein that was detected
primarily in the cells and was the same size as pre-IL-2
synthesized from selected mRNA in a wheat germ extract.
The majority of the recombinant IL-2 made in infected cells
had the correct N-terminus and was secreted. We assume
that it was processed and released from the cell along a
secretory pathway similar to the pathway described for
vertebrates (25). That is, nascent chains of IL-2 would be
translocated across the endoplasmic reticulum (ER), moved
to the Golgi apparatus, and then carried to the plasma
membrane by transport vesicles. The targeting of a secretory
protein to the ER involves the recognition of the signal
peptide, on the nascent polypeptide, by a signal-recognition
particle, which arrests translation. If the translation of a
nascent IL-2 protein in infected insect cells was not arrested,
one would predict that a pre-IL-2 would be synthesized but
not translocated across the ER, and therefore, not secreted.
One explanation for the presence of the Mr 16,000 IL-2
(presumably pre-IL-2) in Ac373-1L2-infected cells is that the
available signal-recognition particles were titrated out by the
excess number of pre-IL-2 signal peptides that were being
synthesized. If this is true, then there may be an upper limit
on the efficiency at which secretory or membrane-bound
proteins with signal peptides can be processed in the insect
cell/baculovirus vector system.
The amount of IL-2 produced and secreted from Ac373-
IL2-infected cells was similar (per ml of medium) to that
obtained in an E. coli/plasmid vector system (10). However,
the amino acid sequence of IL-2 made in E. coli is not
identical to natural IL-2 because of the addition of a bacterial
formylmethionine at the N terminus (10). In bacterial vectors,
it is usually necessary to delete the coding region for signal
peptides to express the mature form of eukaryotic genes for
proteins, like IL-2, with cleavable signal sequences. In
contrast, IL-2 was cloned in the AcNPV expression vector
with the IL-2 protein initiation site and signal peptide se-
quences intact. These signals were recognized in the infected
insect cells and IL-2 was produced with a correct N terminus.
Apparently, the signals required for signal peptide recogni-
tion and processing and protein secretion have been largely
conserved between insects and mammals.
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